Miami, FL, United States of America

John Bixby

USPTO Granted Patents = 3 

 

Average Co-Inventor Count = 3.8

ph-index = 1


Company Filing History:


Years Active: 2013-2024

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: John Bixby: Innovator in Neurite Growth and Central Nervous System Treatments

Introduction

John Bixby is a notable inventor based in Miami, FL (US), recognized for his contributions to the field of neuroscience. He holds a total of 3 patents that focus on innovative treatments for central nervous system disorders. His work has significant implications for the development of therapies aimed at neuronal and axonal damage.

Latest Patents

Bixby's latest patents include groundbreaking compounds that promote neurite outgrowth. One of his patents, titled "Neurite outgrowth promoters and uses thereof," provides compounds useful in treating central nervous system disorders associated with neuronal and/or axonal damage. This patent outlines methods for the preparation of these compounds and related pharmaceutical compositions. Another significant patent is "Kinase inhibitors for the treatment of central and peripheral nervous system disorders," which describes compounds that act as kinase inhibitors, such as ROCK, S6K, and/or PKC inhibitors. These compounds are particularly useful in promoting neurite and axonal growth.

Career Highlights

Throughout his career, John Bixby has worked with esteemed institutions, including the University of Miami and the Torrey Pines Institute for Molecular Studies. His research has contributed to advancements in understanding and treating complex neurological conditions.

Collaborations

Bixby has collaborated with notable colleagues, including Hassan Al-Ali and Vance Lemmon, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

John Bixby is a distinguished inventor whose work in neurite growth and central nervous system treatments continues to influence the field of neuroscience. His innovative patents and collaborations reflect his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…